Thousands of Kenyans are being wrongly diagnosed and treated for the milk linked disease brucellosis, reveals a new study. Now researchers at the Kenya Medical Research Institute (Kemri) and six international institutions, want the responsible test withdrawn from public hospitals.
ILRI and TechnoServe jointly convened a stakeholders’ workshop to deliberate on how best to achieve sustainable livestock services in extensive production systems in Africa.
‘Forty eight out of 108 (44 per cent) cut pork meat samples collected at wet markets in Hưng Yên Province were found to contain the disease-causing bacteria Salmonella. . . .
‘The researchers determined that the probability of pork eaters in northern Hưng Yên Province becoming ill with salmonellosis from consuming infected pork in a given year is 18 per cent. . . .. However, this risk can be avoided,” Nguyễn Việt Hùng, representative for East and Southeast Asia and a senior scientist in eco-health and food safety at the International Livestock Research Institute (ILRI) told Việt Nam News.
‘Prof Eric Fèvre, a researcher of veterinary infectious diseases at the Institute of Infection and Global Health at the University of Liverpool and the International Livestock Research Institute (ILRI) in Nairobi told the Business Daily the close interaction between people and animals worsened the situation.
The following remarks are excerpted from an opinion piece written by Bill Gates and published on his Gates Notes blog. ‘The first promise of any good politician is to make people’s lives better, and scientific research leading to innovation is one of the best ways to honor that promise . . . .’
From the United States comes this good news about a new rule that has gone into effect curtailing use of antibiotics in livestock production with the aim of reducing the rise of antimicrobial resistance to drugs of medical importance.
Lethal bacteria are showing resistance to more and more antibiotics, and financial and legal hurdles are making it harder than ever for science to create effective new drugs. . . . The arsenal of antibiotics is nearly empty. And significant financial and legal hurdles are getting in the way of the already challenging process of discovering effective new ones.